Keyphrases
Neuroblastoma
100%
Tumor
28%
Neuroblastoma Cells
19%
Pediatric
16%
Pediatric Tumors
14%
Neuroblastoma Cell Line
12%
Neuroblastoma Tumor
12%
Pediatric Cancer
10%
Children with Cancer
10%
Organoids
8%
Childhood Cancer
8%
Pediatric Oncology
8%
MYCN Amplification
8%
Therapeutic Target
8%
Precision Oncology
7%
T Cells
7%
Innovative Therapies
7%
High-risk Neuroblastoma
7%
Poor Prognosis
6%
Pediatric Malignancy
6%
Tumor Organoids
6%
Chromothripsis
6%
Tumor Cells
6%
Cyclin D1 (CCND1)
6%
Cyclin-dependent Kinase 4 (CDK4)
6%
Aberrations
5%
Whole Genome Sequencing
5%
High-throughput Screening
5%
Apoptosis
5%
Drug Development
5%
Tumor Subtype
5%
MHC Class II
5%
Xenograft
5%
Natural Killer Cells
5%
Genetic Modification
5%
Cancer Research
5%
Single-cell RNA Sequencing (scRNA-seq)
5%
Medicine and Dentistry
Ganglioneuroblastoma
79%
Neoplasm
43%
Pediatrics
28%
Neuroblastoma Cell
17%
Childhood Cancer
17%
Pediatric Cancer
16%
Organoid
15%
Malignant Neoplasm
13%
Immunotherapy
13%
Solid Malignant Neoplasm
12%
T Cell
12%
Neuroblastoma Cell Line
11%
Disease
9%
Oncology
8%
Cancer
8%
RNA Sequence
7%
Targeted Therapy
7%
Messenger RNA
6%
Personalized Medicine
6%
Experimental Therapy
6%
In Vitro
6%
Protein P53
6%
Xenograft
6%
Programmed Cell Death
6%
Adolescence
5%
Cell Line
5%
